Bunge Global (BG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Nov, 2025Executive summary
Q1 2025 delivered strong execution in a dynamic market, with results exceeding expectations due to activity pull-forward, though net income and EPS declined year-over-year.
Strategic focus on closing the Viterra acquisition, with regulatory approval expected soon; terminated CJ Selecta agreement and announced divestitures in U.S. corn milling and European margarine/spreads.
Closed a joint venture with Repsol, advancing renewable fuels and novel crop feedstocks in Europe.
Expanded share repurchase program to $2.7 billion, with $800 million remaining authorized.
Financial highlights
Q1 2025 diluted EPS was $1.48, down from $1.68; adjusted EPS was $1.81, down from $3.04; net income attributable to shareholders was $201 million, down from $244 million.
Adjusted segment EBIT was $362 million, down from $676 million; net sales were $11,643 million, down from $13,417 million.
Cash and cash equivalents stood at $3.25 billion at March 31, 2025; cash used in operating activities was $285 million.
Adjusted funds from operations were $392 million; discretionary cash flow yield at 10.2%.
Gross profit declined to $597 million from $876 million year-over-year.
Outlook and guidance
Full-year 2025 adjusted EPS guidance reaffirmed at approximately $7.75, excluding impacts from pending acquisitions/divestitures.
Q2 expected to be softer due to earnings pull-forward; full-year cadence now expected to be 60/40 between H1 and H2.
2025 guidance: adjusted tax rate 21–25%, net interest expense $220–250 million, capex $1.5–1.7 billion, D&A ~$490 million.
Agribusiness and specialty oils results forecasted lower than prior outlook; milling expected up from last year.
Management highlights ongoing risks from global economic, agricultural, and geopolitical conditions, including the war in Ukraine and related sanctions.
Latest events from Bunge Global
- Targeting $15+ mid-cycle EPS by 2030, leveraging Viterra synergies and a $3B buyback.BG
Investor Day 202616 Mar 2026 - Strategic transformation, strong governance, and sustainability drive shareholder value.BG
Proxy Filing13 Mar 2026 - Shareholders to vote on key strategic, financial, compensation, and ESG proposals amid major transitions.BG
Proxy Filing13 Mar 2026 - Q3 adjusted EPS was $2.27, with Viterra integration fueling record sales and segment EBIT.BG
Q3 202513 Mar 2026 - Shareholders will vote on financials, board elections, compensation, and a $2.80 dividend.BG
Proxy Filing13 Mar 2026 - 2026 adjusted EPS guided at $7.50–$8.00, with strong segment results and Viterra synergies.BG
Q4 20254 Feb 2026 - Q2 adjusted EPS dropped to $1.73; full-year outlook set at $9.25 amid major transactions.BG
Q2 20242 Feb 2026 - Q3 earnings and margins fell, but full-year adjusted EPS is expected to reach at least $9.25.BG
Q3 202417 Jan 2026 - 2025 adjusted EPS guided to $7.75 as strategic deals close and liquidity remains strong.BG
Q4 20249 Jan 2026